Tag: Prescription Drugs
Baricitinib Superior to Placebo in Refractory Rheumatoid Arthritis
Findings based on patients with previous inadequate response to biologics
Guidelines Updated on Duration of Dual Antiplatelet Tx in CAD
Longer-duration tx represents trade-off between decreased risk of cardiac events, increased bleeding
Improper Prescribing Common at Hospital Discharge of Seniors
Finding among older adults discharged from cardiology, internal medicine services
Tool Guides Duration of Dual Antiplatelet Therapy After PCI
For patients without major bleed, ischemic event at one year after percutaneous coronary intervention
Tocilizumab Treats Rheumatoid Arthritis After Non-TNFi Failure
Better efficacy for tocilizumab versus abatacept and rituximab in patients with first non-TNFi failure
Naltrexone ER Injection Cuts Opioid Relapse Rate in Inmates
Lower rate of relapse compared with usual treatment in trial involving criminal justice offenders
ACP Addresses Skyrocketing Costs of Prescription Medications
ACP recommends transparency in relation to pricing, costs, and comparative value
Antipsychotics Not Effective for Delirium in Hospitalized Patients
No significant effect found for preventing or treating delirium during hospitalization
FDA Wants Generic Opioids to Be Abuse-Deterrent
One more step to combat the epidemic of opioid abuse
Many Doctors Prescribe Opioids for Longer Than CDC Advises
While 99 percent exceed the recommended three-day dosage limit, a quarter write Rx for a full month
